MarketBeat Instant News Alerts 2 hours agoCompass Therapeutics, Inc. (NASDAQ:CMPX) Stock Rated "Moderate Buy" by Sell-Side BrokeragesMarketBeatCompass Therapeutics, Inc. (NASDAQ:CMPX - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the seventeen brokerages that are currently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, three have issued a hNASDAQ:CMPXRead Compass Therapeutics, Inc. (NASDAQ:CMPX) Stock Rated "Moderate Buy" by Sell-Side Brokerages2 hours agoHome BancShares, Inc. (HOMB) - What Are Analysts Thinking About This Stock?MarketBeatHome BancShares, Inc. (NYSE:HOMB - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the ten analysts that are presently covering the company, Marketbeat.com reports. Five equities research analysts have rated the stock with a hold rating and five have issued a buy rating NYSE:HOMBRead Home BancShares, Inc. (HOMB) - What Are Analysts Thinking About This Stock?2 hours agoH. B. Fuller Company (NYSE:FUL) Stock Has Consensus Price Target of $62.88 According to AnalystsMarketBeatH. B. Fuller Company (NYSE:FUL - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the eight research firms that are currently covering the firm, Marketbeat reports. Three equities research analysts have rated the stock with a hold rating, four have assigned a buy rNYSE:FULRead H. B. Fuller Company (NYSE:FUL) Stock Has Consensus Price Target of $62.88 According to Analysts2 hours agogoeasy Ltd. (TSE:GSY) Stock Has Average Target Price of C$42.89MarketBeatgoeasy Ltd. (TSE:GSY - Get Free Report) has earned an average rating of "Reduce" from the nine analysts that are covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a sell recommendation, six have issued a hold recommendation and one has given a buy recomTSE:GSYRead goeasy Ltd. (TSE:GSY) Stock Has Average Target Price of C$42.892 hours agoFirst Busey Corporation (NASDAQ:BUSE) Stock Has Consensus Target Price of $31.00 According to BrokeragesMarketBeatFirst Busey Corporation (NASDAQ:BUSE - Get Free Report) has received an average rating of "Hold" from the seven ratings firms that are currently covering the company, Marketbeat reports. Four equities research analysts have rated the stock with a hold recommendation and three have given a buy recommNASDAQ:BUSERead First Busey Corporation (NASDAQ:BUSE) Stock Has Consensus Target Price of $31.00 According to Brokerages2 hours agoZurn Elkay Water Solutions Cor (NYSE:ZWS) Stock Has Average Target Price of $57.00MarketBeatShares of Zurn Elkay Water Solutions Cor (NYSE:ZWS - Get Free Report) have been assigned an average rating of "Moderate Buy" from the nine brokerages that are covering the firm, Marketbeat reports. Four investment analysts have rated the stock with a hold recommendation and five have assigned a buy NYSE:ZWSRead Zurn Elkay Water Solutions Cor (NYSE:ZWS) Stock Has Average Target Price of $57.00 Trending News111,731 Primerica, Inc. $PRI Shares Acquired by Crossmark Global Holdings Inc.2Lam Research (NASDAQ:LRCX) Upgraded to Buy at Wall Street Zen3Anderson Hoagland & Co. Sells 115,469 Shares of Sumitomo Mitsui Financial Group Inc $SMFG4Insider Buying: Nebius Group (NASDAQ:NBIS) Director Buys $57,823.29 in Stock5Strategy Inc Variable Rate Series A Perpetual Stretch Preferred Stock (NASDAQ:STRC) to Issue Dividend of $0.036Strategy Inc Variable Rate Series A Perpetual Stretch Preferred Stock (NASDAQ:STRC) Shareholders to Collect $0.03 Dividend7BlockchAIn Digital Infrastructure Unveils $1B+ Nebius Data Center Lease Strategy8Prime Medicine (NASDAQ:PRME) Stock Price Up 7.1% - Here's What Happened All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 5 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Corporate Event Transcript Dividend Earnings Earnings Preview Earnings Transcript Highlights Estimates Guidance Insider Trade Lockup Expiration MarketBeat List Articles Options Price SEC Filing Stock List Stock Split Alert Type Keywords More filters Fewer filters Done 2 hours agoRepsol SA (OTCMKTS:REPYY) Stock Now Rated "Buy" by Wall Street AnalystsMarketBeatOTCMKTS:REPYYRead Repsol SA (OTCMKTS:REPYY) Stock Now Rated "Buy" by Wall Street Analysts2 hours agoNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Stock Has Consensus Price Target of $34.50 According to AnalystsMarketBeatNASDAQ:NRXPRead NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Stock Has Consensus Price Target of $34.50 According to Analysts2 hours agoGrindr Inc. (NYSE:GRND) Stock Has Consensus Target Price of $20.00MarketBeatNYSE:GRNDRead Grindr Inc. (NYSE:GRND) Stock Has Consensus Target Price of $20.002 hours agoBlack Diamond Therapeutics, Inc. (NASDAQ:BDTX) Stock Has Consensus Target Price of $11.00MarketBeatNASDAQ:BDTXRead Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Stock Has Consensus Target Price of $11.002 hours agoProFrac Holding Corp. (NASDAQ:ACDC) Stock Has Consensus Price Target of $5.25 According to AnalystsMarketBeatNASDAQ:ACDCRead ProFrac Holding Corp. (NASDAQ:ACDC) Stock Has Consensus Price Target of $5.25 According to Analysts2 hours agoOncobiologics, Inc. (NASDAQ:OTLK) Stock Has Consensus Target Price of $5.20 According to BrokeragesMarketBeatNASDAQ:OTLKRead Oncobiologics, Inc. (NASDAQ:OTLK) Stock Has Consensus Target Price of $5.20 According to Brokerages2 hours agoYext (NYSE:YEXT) Stock Has Average Target Price of $6.33MarketBeatNYSE:YEXTRead Yext (NYSE:YEXT) Stock Has Average Target Price of $6.332 hours agoJinkoSolar Holding Company Limited (JKS) - What Are Investment Firms Saying About This Stock?MarketBeatNYSE:JKSRead JinkoSolar Holding Company Limited (JKS) - What Are Investment Firms Saying About This Stock?2 hours agoGain Therapeutics, Inc. (NASDAQ:GANX) Stock Now Rated "Moderate Buy" by Sell-Side BrokeragesMarketBeatNASDAQ:GANXRead Gain Therapeutics, Inc. (NASDAQ:GANX) Stock Now Rated "Moderate Buy" by Sell-Side Brokerages2 hours agoAbsci Corporation (NASDAQ:ABSI) Stock Rated "Moderate Buy" by Sell-Side AnalystsMarketBeatNASDAQ:ABSIRead Absci Corporation (NASDAQ:ABSI) Stock Rated "Moderate Buy" by Sell-Side Analysts2 hours agoPyxis Oncology, Inc. (NASDAQ:PYXS) Stock Has Consensus Price Target of $8.75 According to BrokeragesMarketBeatNASDAQ:PYXSRead Pyxis Oncology, Inc. (NASDAQ:PYXS) Stock Has Consensus Price Target of $8.75 According to Brokerages2 hours agoIDEAYA Biosciences, Inc. (NASDAQ:IDYA) Stock Has Consensus Target Price of $51.09MarketBeatNASDAQ:IDYARead IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Stock Has Consensus Target Price of $51.092 hours agoiQIYI, Inc. Sponsored ADR (NASDAQ:IQ) Stock Has Average Target Price of $1.73 According to AnalystsMarketBeatNASDAQ:IQRead iQIYI, Inc. Sponsored ADR (NASDAQ:IQ) Stock Has Average Target Price of $1.73 According to Analysts2 hours agoRedwire Corporation (NYSE:RDW) Stock Has Average Price Target of $14.28 According to AnalystsMarketBeatNYSE:RDWRead Redwire Corporation (NYSE:RDW) Stock Has Average Price Target of $14.28 According to Analysts2 hours agoFinning International Inc. (TSE:FTT) Stock Has Average Target Price of C$117.80MarketBeatTSE:FTTRead Finning International Inc. (TSE:FTT) Stock Has Average Target Price of C$117.802 hours agoHinge Health Inc. (HNGE) - What Are Analysts Saying About This Stock?MarketBeatNYSE:HNGERead Hinge Health Inc. (HNGE) - What Are Analysts Saying About This Stock?2 hours agoMNTN Inc. (NYSE:MNTN) Stock Has Consensus Target Price of $18.65MarketBeatNYSE:MNTNRead MNTN Inc. (NYSE:MNTN) Stock Has Consensus Target Price of $18.652 hours agoKnife River Corporation (NYSE:KNF) Stock Has Average Price Target of $69.29MarketBeatNYSE:KNFRead Knife River Corporation (NYSE:KNF) Stock Has Average Price Target of $69.292 hours agoBoston Scientific Q3 Earnings Call HighlightsMarketBeatNYSE:BSXRead Boston Scientific Q3 Earnings Call Highlights2 hours agoWhat Banco Santander Brasil (BSBR) Said on Its Q3 Earnings CallMarketBeatNYSE:BSBRRead What Banco Santander Brasil (BSBR) Said on Its Q3 Earnings Call2 hours agoBrightSpire Capital Q3 Earnings Call HighlightsMarketBeatNYSE:BRSPRead BrightSpire Capital Q3 Earnings Call Highlights2 hours agoCarlisle Companies Q3 Earnings Call HighlightsMarketBeatNYSE:CSLRead Carlisle Companies Q3 Earnings Call Highlights2 hours agoWhat Boot Barn (BOOT) Said on Its Q2 Earnings CallMarketBeatNYSE:BOOTRead What Boot Barn (BOOT) Said on Its Q2 Earnings Call2 hours agoWhat Bausch + Lomb (BLCO) Said on Its Q3 Earnings CallMarketBeatNYSE:BLCORead What Bausch + Lomb (BLCO) Said on Its Q3 Earnings Call Featured Articles and OffersNewmont’s Record Quarter Shows Why Gold’s Floor Is the Real StoryBy Chris Markoch | October 25, 2026Two charts tell you the future…From Golden Portfolio (Ad)Is Texas Instruments Setting Up for Its Next Big Breakout?By Thomas Hughes | October 22, 2026Boeing Got Its MAX 10 Approval, But Q3 Delivered a Reality CheckBy Dan Schmidt | October 28, 2026Comfort Systems Earnings: AI Slowdown or More Growth Ahead?By Dan Schmidt | October 26, 2026Why Gerardo Del Real says wait before buying uranium stocksFrom Digest Publishing (Ad)Coca-Cola Stock Is Everything AI Isn’t—And That’s Its Biggest StrengthBy Thomas Hughes | October 27, 2026Consumer Staples Are Up 12% This Year—These 3 Beverage Stocks Are Leading the WayBy Dan Schmidt | October 25, 2026 Alert CategoriesAll AlertsAnalystCongressional TradesConsensusCorporate BuybackCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeLockup ExpirationMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Page 1 of 288 1234567 Earlier › Earliest » Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
